Ilevro Suspension/ Drops
Product Images NDC 0078-0743

Product Visual Gallery

This gallery contains 2 technical images submitted to the FDA as part of the official labeling for Ilevro (NDC 0078-0743). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Novartis Pharmaceuticals Corporation, these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Principal Display Panel Ndc 0078-0743-03 Sterile Ilevro® (nepafenac Ophthalmic Suspension) 0.3% 3 mL Rx Only Novartis (Carton)

This is a description of ILEVRO® Suspension 0.3%, an ophthalmic medication manufactured by Alcon Research, Ltd, Belgium and distributed by Novartis Pharmaceuticals. It contains the active ingredient nepafenac 035 and is used topically for ophthalmic purposes. The product should be shaken well before use and stored between 20°C-25°C while protected from light. The package includes detailed information about inactive ingredients, dosage, and manufacturer details.*

FDA Label Image

Structural Formula Of Nepafenac (Chemical)

* These product label images have been analyzed using experimental machine learning. Please verify findings with the primary label text.